LIVINGSTON, N.J., April 21 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that Medical Device & Diagnostic Industry (MD&DI) magazine has distinguished the STA(TM) System as a winner of the 2008 Medical Design Excellence Award (MDEA) in the "dental instruments, equipment and supplies" product category. Of the 33 products to receive an MDEA this year, Milestone's STA System was one of only two winning products that serve dental practitioners.
Sponsored by MD&DI, the Medical Design Excellence Awards (MDEA) competition is the premier awards program for the medical technology community. It recognizes the achievements of medical device manufacturers, their suppliers and the many people behind the scenes -- engineers, scientists, designers and clinicians -- who are responsible for the groundbreaking innovations that are changing the face of healthcare. MDEA-winning entries excel in the areas of product innovation, design and engineering achievement, end-user benefit and cost effectiveness in manufacturing and healthcare delivery. To select the 2008 winners, a comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third party jurors with expertise in biomedical engineering, human factors, medicine and diagnostics. The 2008 jury selected 33 winners in 10 medical product categories.
"We are delighted that our award winning STA System continues to be recognized by leading industry publications as the best of the best in dental innovations," stated Joe Martin, Chief Executive Officer of Milestone. In July 2007, noted industry publication Dentistry Today featured the STA System as one of the Top 100 Products in 2007. "These industry acknowledgements are helping Milestone and its global distributor network to accelerate industry adoption of the STA System as the new standard of care for dental injections."
"The team at Milestone Scientific is honored by this prestigious award. Over the years, our technology has been validated in numerous clinical studies published in professional journals documenting positive clinical results. This award, however, represents a new category of validation for us, so we are very pleased indeed," noted Dr. Mark Hochman, Director of Clinical Affairs of Milestone and STA System inventor.
The award ceremony will be held June 4, 2008 during the Medical Design and Medical Manufacturing East 2008 Conference and Exposition at the Jacob K. Javits Convention Center in New York City. For more information about the 2008 MDEA award winners, please visit http://www.devicelink.com/expo/awards/awards/index.php?catId=3&year=-1.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System is a computer-controlled local anesthesia delivery system which uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the
timing and financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These statements
involve a number of risks and uncertainties and are based on assumptions
involving judgments with respect to future economic, competitive and market
conditions and future business decisions, all of which are difficult or
impossible to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual results to
differ materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected revenue
growth, changes in our operating expenses, adverse patent rulings, FDA or
legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time
in Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report on Form
10-KSB for the year ended December 31, 2007. The forward looking-statements
in this press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or update
publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief Strategy Officer
407-585-1080 or via email at firstname.lastname@example.org
|SOURCE Milestone Scientific Inc.|
Copyright©2008 PR Newswire.
All rights reserved